High-dose intravenous vitamin C is one of the most discussed integrative approaches among people with cancer and autoimmune conditions. It’s also one of the most misunderstood. Here’s what the research shows.
Why IV and oral vitamin C are different
The gut limits how much vitamin C the body absorbs. Research published in the Annals of Internal Medicine (Padayatty et al., 2004) showed that intravenous vitamin C can reach blood levels far higher than are possible by mouth. That difference is why researchers study IV vitamin C separately from supplements.
What the research shows in cancer
- Laboratory and animal studies have found that very high vitamin C concentrations can affect cancer cells, which prompted human research.
- Early-phase human trials have mostly looked at safety and quality of life, with some reporting improvements in fatigue and other symptoms during treatment.
- No large randomized trials have shown that IV vitamin C improves survival or shrinks tumors. The National Cancer Institute’s summary for health professionals describes the evidence as limited.
- Interactions with chemotherapy remain an open question. Some studies suggest no harm with certain regimens; the question hasn’t been settled across all treatments.
What about autoimmune conditions?
Vitamin C plays roles in immune function, and deficiency is associated with poorer immune health. Evidence that high-dose IV vitamin C treats autoimmune disease comes mainly from small studies and case reports, not controlled trials.
Safety considerations
- G6PD deficiency: high-dose IV vitamin C can cause serious red blood cell breakdown (hemolysis) in people with this inherited enzyme deficiency. Screening is standard before high doses.
- Kidney problems: vitamin C is converted to oxalate, which can contribute to kidney stones or kidney injury, especially with existing kidney disease.
- Iron overload conditions such as hemochromatosis require caution.
- False blood sugar readings: high blood levels of vitamin C can cause some fingerstick glucose meters to show falsely high results.
- Chemotherapy and radiation timing: always coordinate with your oncology team.
Talking to your oncology team
If you’re considering IV vitamin C during cancer treatment, discuss it with your oncologist first, including timing relative to chemotherapy or radiation. For practical guidance on how to raise supplements with your care team, see our page on supportive care during and after cancer treatment.
Frequently asked questions
Does IV vitamin C cure cancer?
No. There is no evidence that it cures cancer, and large trials showing survival benefit don’t exist.
Can I take IV vitamin C during chemotherapy?
It depends on your treatment. Discuss it with your oncologist before starting.
Why is G6PD testing needed?
People with G6PD deficiency can develop dangerous red blood cell breakdown from high-dose vitamin C.
Is oral vitamin C the same?
No. Oral vitamin C can’t reach the blood levels studied with IV administration.
This article is an educational review of published research. It is not a recommendation for any treatment and is not a substitute for care from your oncology team. From Venturis Clinic in Oklahoma City.
By Alvin Philipose, DC, ICCP
Sources
- Padayatty SJ, et al. Vitamin C pharmacokinetics: implications for oral and intravenous use. Annals of Internal Medicine. 2004;140(7):533–537.
- National Cancer Institute. High-Dose Vitamin C (PDQ®) – Health Professional Version. cancer.gov
